228 related articles for article (PubMed ID: 18786092)
1. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury.
Bhuiyan MS; Fukunaga K
Cardiovasc Ther; 2008; 26(3):224-32. PubMed ID: 18786092
[TBL] [Abstract][Full Text] [Related]
2. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
[TBL] [Abstract][Full Text] [Related]
3. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
5. Toxic proteins released from mitochondria in cell death.
Saelens X; Festjens N; Vande Walle L; van Gurp M; van Loo G; Vandenabeele P
Oncogene; 2004 Apr; 23(16):2861-74. PubMed ID: 15077149
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo.
Bhuiyan MS; Fukunaga K
Eur J Pharmacol; 2007 Feb; 557(2-3):168-77. PubMed ID: 17182030
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
[TBL] [Abstract][Full Text] [Related]
8. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity.
van Loo G; van Gurp M; Depuydt B; Srinivasula SM; Rodriguez I; Alnemri ES; Gevaert K; Vandekerckhove J; Declercq W; Vandenabeele P
Cell Death Differ; 2002 Jan; 9(1):20-6. PubMed ID: 11803371
[TBL] [Abstract][Full Text] [Related]
9. [Mitochondrial intermembrane space proteins in apoptosis process].
Bednarek J; Kiliańska ZM
Postepy Biochem; 2005; 51(4):447-58. PubMed ID: 16676580
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.
Martins LM; Morrison A; Klupsch K; Fedele V; Moisoi N; Teismann P; Abuin A; Grau E; Geppert M; Livi GP; Creasy CL; Martin A; Hargreaves I; Heales SJ; Okada H; Brandner S; Schulz JB; Mak T; Downward J
Mol Cell Biol; 2004 Nov; 24(22):9848-62. PubMed ID: 15509788
[TBL] [Abstract][Full Text] [Related]
11. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.
Wang P; Hu Y; Yao D; Li Y
Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467
[TBL] [Abstract][Full Text] [Related]
12. Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.
Wang K; Zhang J; Liu J; Tian J; Wu Y; Wang X; Quan L; Xu H; Wang W; Liu H
Age (Dordr); 2013 Jun; 35(3):733-46. PubMed ID: 22535253
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
14. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.
Chao JR; Parganas E; Boyd K; Hong CY; Opferman JT; Ihle JN
Nature; 2008 Mar; 452(7183):98-102. PubMed ID: 18288109
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death.
Kuninaka S; Nomura M; Hirota T; Iida S; Hara T; Honda S; Kunitoku N; Sasayama T; Arima Y; Marumoto T; Koja K; Yonehara S; Saya H
Oncogene; 2005 Aug; 24(34):5287-98. PubMed ID: 16007220
[TBL] [Abstract][Full Text] [Related]
16. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
Winkler J; Rand ML; Schmugge M; Speer O
Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
[TBL] [Abstract][Full Text] [Related]
17. Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.
Hong SK; Cha MK; Kim IH
Free Radic Biol Med; 2006 Jan; 40(2):275-84. PubMed ID: 16413409
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial serine protease HtrA2/Omi: an overview.
Vande Walle L; Lamkanfi M; Vandenabeele P
Cell Death Differ; 2008 Mar; 15(3):453-60. PubMed ID: 18174901
[TBL] [Abstract][Full Text] [Related]
19. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury.
Fu J; Lin G; Wu Z; Ceng B; Wu Y; Liang G; Qin G; Li J; Chiu I; Liu D
Biochem Biophys Res Commun; 2006 Oct; 349(2):504-12. PubMed ID: 16942749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]